SAM
IRWD icon

Shell Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Shell Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$28K Sell
21,021
-5,668
-21% -$5.87K ﹤0.01% 988
2025
Q2 		$19K Hold
26,689
– – ﹤0.01% 1230
2025
Q1 		$39K Sell
26,689
-1,120
-4% -$2.67K ﹤0.01% 1184
2024
Q4 		$123K Hold
27,809
– – 0.01% 996
2024
Q3 		$115K Buy
+27,809
New +$150K 0.01% 1018
2024
Q1 		$186K Sell
28,496
-2,856
-9% -$34.7K 0.01% 848
2023
Q4 		$359K Sell
31,352
-9,478
-23% -$93.8K 0.02% 640
2023
Q3 		$393K Sell
40,830
-633
-2% -$6.2K 0.02% 658
2023
Q2 		$441K Sell
41,463
-234
-0.6% -$2.52K 0.02% 627
2023
Q1 		$439K Sell
41,697
-144
-0.3% -$1.61K 0.02% 615
2022
Q4 		$518K Sell
41,841
-8,838
-17% -$100K 0.02% 518
2022
Q3 		$525K Sell
50,679
-13,280
-21% -$151K 0.02% 553
2022
Q2 		$737K Buy
63,959
+109
+0.2% +$1.28K 0.02% 521
2022
Q1 		$803K Sell
63,850
-9,445
-13% -$108K 0.02% 576
2021
Q4 		$855K Buy
73,295
+338
+0.5% +$4.15K 0.02% 633
2021
Q3 		$953K Sell
72,957
-3,130
-4% -$40.5K 0.02% 537
2021
Q2 		$979K Buy
76,087
+21,548
+40% +$247K 0.02% 583
2021
Q1 		$610K Buy
54,539
+32,112
+143% +$339K 0.01% 767
2020
Q4 		$255K Hold
22,427
– – 0.01% 1054
2020
Q3 		$202K Hold
22,427
– – ﹤0.01% 1043
2020
Q2 		$231K Buy
22,427
+11,157
+99% +$114K 0.01% 986
2020
Q1 		$114K Sell
11,270
-172
-2% -$2.02K ﹤0.01% 1105
2019
Q4 		$152K Sell
11,442
-281
-2% -$3.1K ﹤0.01% 1159
2019
Q3 		$101K Sell
11,723
-101
-0.9% -$981 ﹤0.01% 1194
2019
Q2 		$129K Sell
11,824
-2,616
-18% -$29.3K ﹤0.01% 1158
2019
Q1 		$164K Hold
14,440
– – ﹤0.01% 1127
2018
Q4 		$125K Sell
14,440
-1,194
-8% -$13.7K ﹤0.01% 1081
2018
Q3 		$242K Hold
15,634
– – ﹤0.01% 1088
2018
Q2 		$250K Sell
15,634
-883
-5% -$13.1K 0.01% 1040
2018
Q1 		$213K Hold
16,517
– – ﹤0.01% 1048
2017
Q4 		$207K Buy
+16,517
New +$216K ﹤0.01% 1045

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Shell Asset Management's IRWD Position: Q3 2025 in Review

Shell Asset Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 21% in Q3 2025, selling an estimated $5.87K and leaving 21,021 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Shell Asset Management first reported a position in IRWD in Q4 2017 and has held it in 31 quarters since. The position peaked at $979K in Q2 2021. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

  • Shell Asset Management held 21,021 shares of Ironwood Pharmaceuticals worth $28K as of Q3 2025.
  • Shell Asset Management sold 5,668 Ironwood Pharmaceuticals shares in Q3 2025, an estimated $5.87K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #988 holding.
  • Shell Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 31 quarters since.
  • Shell Asset Management's Ironwood Pharmaceuticals position peaked at $979K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.